Marlborough medical device maker Hologic announced Tuesday it has received U.S. Food & Drug Administration approval for its 3DQuorum Imaging Technology to reduces image interpretation time.
The company said when combined with its high-resolution imaging technology, this new technology reduces the number of images needing to be reviewed without compromising image quality or accuracy through using artificial intelligence to find the best images.
The number of images to be reviewed is reduced by 66%, according to Hologic, saving an average of one hour per eight hours of image interpretation time.
The technology is available for use with existing and future Hologic 3D mammography systems.
